Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Cardio Diagnostics Holdings (CDIO) Depreciation & Amortization (IS) (2022 - 2025)

Cardio Diagnostics Holdings' Depreciation & Amortization (IS) history spans 4 years, with the latest figure at $45438.0 for Q1 2025.

  • For Q1 2025, Depreciation & Amortization (IS) rose 848.01% year-over-year to $45438.0; the TTM value through Mar 2025 reached $60383.0, up 214.66%, while the annual FY2024 figure was $19738.0, 2.9% up from the prior year.
  • Depreciation & Amortization (IS) for Q1 2025 was $45438.0 at Cardio Diagnostics Holdings, up from $5349.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $45438.0 in Q1 2025 and bottomed at $4000.0 in Q1 2022.
  • The 4-year median for Depreciation & Amortization (IS) is $4793.0 (2023), against an average of $7719.8.
  • The largest annual shift saw Depreciation & Amortization (IS) changed 0.0% in 2024 before it skyrocketed 848.01% in 2025.
  • A 4-year view of Depreciation & Amortization (IS) shows it stood at $4000.0 in 2022, then grew by 20.05% to $4802.0 in 2023, then rose by 11.39% to $5349.0 in 2024, then soared by 749.47% to $45438.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Depreciation & Amortization (IS) are $45438.0 (Q1 2025), $5349.0 (Q4 2024), and $4802.0 (Q3 2024).